CTX-712

Near Add Your Location

Accepting patients

Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Learn more
  • CLK Inhibitor
  • Phase 1/2